phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
Published 7 years ago • 219 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
1:07
phase ii results for pembrolizumab monotherapy in metastatic tnbc
-
1:08
4-year monarche results: increasing benefits with abemaciclib et for er /her2- high-risk early bc
-
2:28
expert discusses promise of abemaciclib for breast cancer treatment
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
1:57
monarcher: final os results of abemaciclib in hr , her breast cancer
-
3:12
treatments for hr , her2-negative metastatic breast cancer
-
2:26
updated results of the monaleesa-2 trial in hr /her2- breast cancer
-
1:19
advantages to treating hr patients with breast cancer with abemaciclib
-
1:26
monarche: investigating adjuvant abemacicilib for high-risk hr breast cancer
-
2:02
dr. dickler on monarch 1 results in hr /her2- breast cancer
-
7:09
abemaciclib for hr-positive metastatic breast cancer
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer